Format

Send to

Choose Destination
Semin Oncol. 1999 Apr;26(2):202-16.

The challenge of locally advanced prostate cancer.

Author information

1
Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA.

Abstract

Locally advanced prostate cancer can be reliably identified and has a disease-specific death rate of approximately 75%. Monotherapy treatment options have limited efficacy for locally advanced disease. Multimodality therapy may improve survival. This article reviews the current results of multimodality therapy, including hormonal therapy plus radiation therapy, hormonal therapy plus radical prostatectomy, and brachytherapy plus external-beam radiation therapy (EBRT), and presents current ideas for novel multimodality approaches.

PMID:
10597731
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center